A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.
Pfizer
Fusion Pharmaceuticals Inc.
City of Hope Medical Center
CureOne
Masonic Cancer Center, University of Minnesota